TY  - GEN
AU  - Hou,Ming-Mo
AU  - Wang,Zhijie
AU  - Janku,Filip
AU  - Piha-Paul,Sarina
AU  - Naing,Aung
AU  - Hong,David
AU  - Westin,Shannon
AU  - Coleman,Robert L
AU  - Sood,Anil K
AU  - Tsimberidou,Apostolia M
AU  - Subbiah,Vivek
AU  - Wheler,Jennifer
AU  - Zinner,Ralph
AU  - Lu,Karen
AU  - Meric-Bernstam,Funda
AU  - Fu,Siqing
TI  - Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience
SN  - 1949-2553
PY  - 2018///0117
KW  - Adult
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Carcinoma, Ovarian Epithelial
KW  - Clinical Trials, Phase I as Topic
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasms, Glandular and Epithelial
KW  - Ovarian Neoplasms
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.9048
ER  -